Squamous cell carcinoma of the skin and voriconazole therapy in lung transplant recipients: A case series

Squamous cell carcinoma of the skin and voriconazole therapy in lung transplant recipients: A case series

Background: Prolonged voriconazole therapy may be associated with skin squamous cell carcinoma (SCC) in lung transplant (LTx) patients. This is of concern given the frequent use of voriconazole in the LTx setting. The impact of voriconazole therapy on the risk of developing skin SCC in an Australian...

Full description

Bibliographic Details
Main Authors: Kong, D.C.M (Author), Levvey, B. (Author), Morrissey, C.O (Author), Neoh, C.F (Author), Slavin, M.A (Author), Snell, G.I (Author), Stewart, K. (Author)
Format: Article
Language:English
Published: Society of Hospital Pharmacists of Australia 2017
Subjects:
adult
aged
algorithm
antibiotic prophylaxis
antifungal therapy
antimetabolite
Article
Australia
calcineurin inhibitor
cancer chemotherapy
cancer radiotherapy
cancer recurrence
cancer risk
cancer surgery
capecitabine
cohort analysis
cotrimoxazole
cyclosporin
cytomegalovirus infection
drug blood level
drug exposure
female
ganciclovir
graft recipient
histopathology
human
hyperimmune globulin
immunosuppressive treatment
lung graft rejection
Lung transplant
lung transplantation
major clinical study
male
medical record review
metastasis
middle aged
multiple cancer
mycosis
parotid gland cancer
parotidectomy
Pneumocystis pneumonia
prednisolone
retrospective study
scoring system
Skin squamous cell carcinoma
squamous cell skin carcinoma
sun exposure
tacrolimus
treatment duration
valaciclovir
valganciclovir
voriconazole
Voriconazole
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items